ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr | ₹-131 Cr | ₹70 Cr |
What is the latest Consolidated Net Profit of ORCHID PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹46 Cr |
Mar2022 | ₹-1.95 Cr |
Mar2021 | ₹-117 Cr |
Mar2020 | ₹-131 Cr |
Mar2019 | ₹70 Cr |
How is Consolidated Net Profit of ORCHID PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹46 Cr | Positive | |
Mar2022 | ₹-1.95 Cr | Negative | |
Mar2021 | ₹-117 Cr | Negative | |
Mar2020 | ₹-131 Cr | Negative | |
Mar2019 | ₹70 Cr | - |
Compare Consolidated Net Profit of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹5,378.3 Cr | 1.4% | 2.7% | 175.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 1.4% |
2.7% |
175.1% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses